Over the past three decades, advances in molecular imaging have enabled us to study the living human brain and to understand changes in brain chemistry associated with aging, depression and memory problems. Understanding changes in brain chemistry may help us find more effective treatments targets for such conditions such as depression, Alzheimer and Parkinson’s Disease.

Current Opportunities to Participate in our Studies

Molecular Imaging of Depression in Aging and Parkinson’s Disease 

Are you over 55 and feeling depressed? Have you been diagnosed with Parkinson’s disease and are feeling depressed? Symptoms of depression in older adults are common yet often go undetected. Symptoms could include feelings of sadness or hopelessness, loss of energy, inability to enjoy pleasurable activities, changes in appetite or sleeping patterns, poor concentration/memory. If you are feeling depressed and are in good physical health, you may be eligible to participate in a research study involving treatment. 

Qualified people will participate at no cost to them, will be compensated for their time. Transportation will be provided. 

For more information about the research study, please call us at 410-550-4192 or email us at [email protected].  

Read about our Depression studies.

Principal Investigator: Gwenn Smith, PhD (IRB Protocol No: IRB00269869).

Serotonin Modulation in Mild Cognitive Impairment 

Are you more forgetful lately? Do you have trouble with the names of people you’ve met recently? Do you get lost in new places? Do you have a greater tendency to misplace things? Do other people notice that you are forgetful? If you are age 55 or over, having memory problems, not taking antidepressant medication and in good health, you may be eligible to participate in a research study. 

Qualified people will participate at no cost to them, will be compensated for their time. Transportation will be provided. 

For more information about the research study, please call us at 410-550-4192 or email us at [email protected]

Read about our studies in Mild Cognitive Impairment.

Principal Investigator: Gwenn Smith, PhD, IRB Protocol No: NA_00026190